Clinical Trials for Mesothelioma Patients—A Study of Safety and Tolerability of Intravenous CRS-207: Contacts

Read about the contacts for a current clinical trial about the safety and tolerability of intravenous CRS-207 in patients with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Contacts
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Baltimore, Maryland, United States, 21231
Contact: Alice Pons
410-502-9380
ponsal@jhmi.edu
Principal Investigator: Dung Le, MD

National Cancer Institute, NCI
Bethesda, Maryland, United States, 20892
Contact: Barbara Schuler, R.N.
301-435-5398
schulerb@navmed.nci.nih.gov
Principal Investigator: Raffit Hassan, M.D.

University of Pennsylvania Abramson Family Cancer Research Center
Philadelphia, Pennsylvania, United States, 19104
Contact: Adri Recio, RN
215-573-6760
arecio@mail.med.upenn.edu
Principal Investigator: Daniel H Sterman, MD

Mary Crowley Cancer Research Center
Dallas, Texas, United States, 75201
Contact: Joyce Bolluyt, RN, CRC
214-658-1943
jbolluyt@marycrowley.org
Contact: JR Doan
214-658-1943
jdoan@marycrowley.org
Principal Investigator: John Nemunaitis, MD

If you or a loved one has been diagnosed with an Asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading Asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.